Effective pharmacological treatment for obesity exists
The Current State of GLP-1 Drugs 2023 research from IQVIA has shown that demand for GLP-1 drugs has accelerated since early 2020, corresponding to the launches of Ozempic, Wegovy and Mounjaro variations
After consulting with a weight loss physician, I hesitantly started taking a glucagon-like peptide-1 (GLP-1) receptor agonist (Zepbound, in my case) approximately two years ago, and, in short, its been life-changing for me in the best way
Popularity spiked dramatically following Wegovy's approval, with prescriptions doubling in 2022 and again in 2023
Genomics 29 , 773776 (1995)
How you take semaglutide for weight loss can vary slightly depending on if you are taking Wegovy, Ozempic, or compounded semaglutide